Financhill
Back

EyePoint Pharmaceuticals Vs. Concentrix Industry Stock Comparison

Sell
35

EYPT
EyePoint Pharmaceuticals

Last Price:
$5.39
Seasonality Move:
9.92%
Sell
34

CNXC
Concentrix

Last Price:
$48.81
Seasonality Move:
-6.23%
Sell
35
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $5.38. The Score for EYPT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Concentrix (CNXC) is a Sell

Is Concentrix a Buy, Sell or Hold?

  • The current Concentrix [CNXC] share price is $48.82. The Score for CNXC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CNXC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $5.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNXC Stock Price Chart

What is Concentrix's stock price today?

  • The Concentrix share price today is $48.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNXC is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 46.75 Sell
Chaikin Money Flow: 796700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.94 - 6.72) Sell
Bollinger Bands (100): (5.93 - 8.41) Sell

CNXC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.18 Buy
Relative Strength Index (14 RSI): 50.08 Buy
Chaikin Money Flow: 654227 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.61 - 53.49) Buy
Bollinger Bands (100): (42 - 50.68) Buy

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.81 Buy
20-day SMA: 5.53 Sell
50-day SMA: 6.18 Sell
200-day SMA: 8.23 Sell
8-day EMA: 4.96 Buy
20-day EMA: 5.41 Sell
50-day EMA: 6.17 Sell
200-day EMA: 8.61 Sell

CNXC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.94 Sell
20-day SMA: 49.42 Sell
50-day SMA: 47.98 Buy
200-day SMA: 53.35 Sell
8-day EMA: 48.35 Buy
20-day EMA: 40.69 Buy
50-day EMA: 24.64 Buy
200-day EMA: 7.81 Buy

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Concentrix Earnings Growth & CNXC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.37 per share, an increase this year of $0.29 per share, and an increase next year of $1.12 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Concentrix Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):